Cargando…

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

Increased expression of tumour-associated trypsin inhibitor (TATI) in tumour tissue and/or serum has been associated with poor survival in various cancer forms. Moreover, a proinvasive function of TATI has been shown in colon cancer cell lines. In this study, we have examined the prognostic signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaber, A, Johansson, M, Stenman, U-H, Hotakainen, K, Pontén, F, Glimelius, B, Bjartell, A, Jirström, K, Birgisson, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696764/ https://www.ncbi.nlm.nih.gov/pubmed/19384300 http://dx.doi.org/10.1038/sj.bjc.6605047

Ejemplares similares

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients
por: Gaber, Alexander, et al.
Publicado: (2010)

Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
por: Gaber, Alexander, et al.
Publicado: (2011)

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
por: Wallin, U, et al.
Publicado: (2011)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
por: Halila, H., et al.
Publicado: (1988)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
por: Halila, H., et al.
Publicado: (1987)

Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases.
por: Haglund, C., et al.
Publicado: (1986)

Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.
por: Venesmaa, P., et al.
Publicado: (1994)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
por: Jonsson, Liv, et al.
Publicado: (2011)

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
por: Enblad, Malin, et al.
Publicado: (2023)

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status
por: Sjöblom, Anni, et al.
Publicado: (2021)

The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma
por: Hotakainen, K, et al.
Publicado: (2002)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
por: Kressner, U., et al.
Publicado: (1998)

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
por: Birgisson, Helgi, et al.
Publicado: (2011)

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
por: Siesing, Christina, et al.
Publicado: (2017)

SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours
por: López‐Sánchez, Laura M., et al.
Publicado: (2019)

Proceedings: Independent responses of different binding sites on ehrlich ascites tumour cells to trypsin and trypsin inhibitor.
por: Whur, P., et al.
Publicado: (1974)

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells
por: Lippolis, G, et al.
Publicado: (2013)

Detection of Biomarkers with Solid-Phase Proximity Ligation Assay in Patients with Colorectal Cancer
por: Ghanipour, Lana, et al.
Publicado: (2016)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Association of tricellulin expression with poor colorectal cancer prognosis and metastasis
por: Zhang, Jin-Xiu, et al.
Publicado: (2020)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

THE INACTIVATION OF TRYPSIN : IV. THE ADSORPTION OF TRYPSIN BY CHARCOAL.
por: Northrop, John H.
Publicado: (1923)

Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study
por: Brändstedt, Jenny, et al.
Publicado: (2012)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
por: Sundström, Magnus, et al.
Publicado: (2010)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
por: Jonsson, Liv, et al.
Publicado: (2011)

Lipoid Thromboplastin and Trypsin
por: Milstone, J. H., et al.
Publicado: (1954)

Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours
por: Zheng, Xiuli, et al.
Publicado: (2022)

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer
por: Takahashi, Y, et al.
Publicado: (2013)

Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer.
por: Higashiyama, M., et al.
Publicado: (1990)

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
por: Boman, Karolina, et al.
Publicado: (2013)

ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND
por: Kunitz, M., et al.
Publicado: (1936)

Tumour markers of prognosis in colorectal cancer
por: McLeod, H L, et al.
Publicado: (1999)

Proceedings: Autoradiography of Ehrlich ascites tumours treated with soybean trypsin inhibitor in vivo.
por: Whur, P., et al.
Publicado: (1975)

CRYSTALLINE TRYPSIN : IV. REVERSIBILITY OF THE INACTIVATION AND DENATURATION OF TRYPSIN BY HEAT
por: Northrop, John H.
Publicado: (1932)

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer
por: Lin, Qi, et al.
Publicado: (2019)

Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kja4cfm4kacgckksarbbj7fbca